Stimulator Implant for Stroke Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new device designed to help stroke survivors improve their walking ability. The process involves implanting a stimulator (IRS-8), setting it up for home use, and monitoring its effects over several months. It suits individuals who had a stroke over six months ago, can walk with some assistance, and struggle with slow walking speeds. Participants must have stable health conditions and be prepared for follow-up appointments.
As an unphased trial, this study provides a unique opportunity for participants to contribute to innovative research that could enhance rehabilitation options for stroke survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that this implanted stimulator is safe for stroke recovery?
Research shows that functional electrical stimulation (FES), such as the IRS-8 device, has been used in individuals with neurological disorders, including those recovering from a stroke. Although specific safety data for the IRS-8 is unavailable, studies have found FES to improve physical abilities and consider it safe.
For the IST 12 and IST 16 devices, research on brain-computer interfaces (BCIs) has shown promise in aiding stroke recovery. BCIs use brain signals to control external devices, which can enhance movement skills. While specific safety data for IST 12 and IST 16 is lacking, BCIs have been used safely in stroke recovery.
Overall, these treatments are undergoing testing to confirm their safety and effectiveness.12345Why are researchers excited about this trial?
Researchers are excited about the Stimulator Implant for Stroke Recovery because it offers a novel approach to rehabilitation by directly stimulating the nervous system. Unlike traditional stroke recovery methods that often rely on physical therapy and medication, this implant is designed to facilitate walking by creating advanced controllers tailored to the individual's needs. This innovative technique aims to enhance recovery by providing continuous, targeted stimulation, potentially leading to more effective and faster improvements in mobility for stroke survivors.
What evidence suggests that this stimulator implant is effective for stroke recovery?
Research has shown that devices like IRS-8, implanted in the body, help stroke survivors walk better by sending electrical signals to stimulate muscles. This trial will evaluate IRS-8, which uses functional electrical stimulation (FES) to enhance walking ability and speed. Additionally, the trial will study IST 12 and IST 16, brain-computer interfaces (BCIs) that have helped stroke patients regain movement by connecting brain signals to external devices. Together, these methods offer hope for improving mobility in stroke survivors.24678
Who Is on the Research Team?
Nathan Makowski, PhD
Principal Investigator
MetroHealth System, Ohio
Are You a Good Fit for This Trial?
This trial is for stroke survivors aged 21-75 who walk slower than normal due to the stroke. They should be at least 6 months post-stroke, have certain levels of muscle stiffness and motor function, and not need more than one person's help to walk. Participants must also be neurologically stable, speak English, not pregnant, without severe cognitive issues or medical conditions that increase fall risk.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Implantation, Controller Development, and Evaluation
Participants undergo surgery to implant a stimulator and electrodes, followed by training to use the device for walking assistance. Advanced controllers for walking are developed and evaluated over several months.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with evaluations at 18 and 44 weeks post-implant.
What Are the Treatments Tested in This Trial?
Interventions
- IRS-8
- IST 12 & IST 16
IRS-8 is already approved in United States for the following indications:
- Improving walking in stroke survivors
Find a Clinic Near You
Who Is Running the Clinical Trial?
MetroHealth Medical Center
Lead Sponsor
Cleveland State University
Collaborator
Case Western Reserve University
Collaborator
Louis Stokes VA Medical Center
Collaborator